Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells
about
Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progressionEMT-Inducing Molecular Factors in Gynecological CancersRole of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapyDecreased peritoneal ovarian cancer growth in mice lacking expression of lipid phosphate phosphohydrolase 1.CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis.Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration.Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.Phospholipase Cgamma activation drives increased production of autotaxin in endothelial cells and lysophosphatidic acid-dependent regression.Stat3 mediates expression of autotaxin in breast cancerCytosolic phospholipase A2 and lysophospholipids in tumor angiogenesisAssociation of lipid metabolism with ovarian cancerCD47 signaling regulates the immunosuppressive activity of VEGF in T cells.Aiming drug discovery at lysophosphatidic acid targets.Effects of gintonin on the proliferation, migration, and tube formation of human umbilical-vein endothelial cells: involvement of lysophosphatidic-acid receptors and vascular-endothelial-growth-factor signaling.Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosisL-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth.Vinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma.Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progressionGalectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin.Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.Aberrant lipid metabolism: an emerging diagnostic and therapeutic target in ovarian cancer.Soluble VEGF receptor 1 (sFLT1) induces non-apoptotic death in ovarian and colorectal cancer cellsRegression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathyArguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.Roles of LPA in ovarian cancer development and progression.Lysophospholipids and Their Receptors Serve as Conditional DAMPs and DAMP Receptors in Tissue Oxidative and Inflammatory Injury.Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway.Overexpression of autotaxin is associated with human renal cell carcinoma and bladder carcinoma and their progression.Placental autotaxin expression is diminished in women with pre-eclampsia.
P2860
Q24616764-8450B543-1A17-4025-91F0-6051D67C880DQ26781912-94761E81-BEA3-4C8A-86C5-947C61B4C73AQ27015257-2F2B33FC-0FF4-4E39-8763-111122C677EDQ30300375-2D837B12-FB4F-4662-8A88-5844B42F5752Q33618348-9CBF96D1-83AE-487D-847B-73498E407477Q33739306-C8EE3D4A-C3D0-4ED6-B13B-CB8456BFEECBQ33753311-8FF88069-537E-48A3-8BEA-F6FB394755B2Q33826570-6B09BDBD-FD52-4BD4-B32D-E1D1365BD584Q34091068-BF7B1365-5A57-497F-A141-8741830F0593Q34145860-C5791562-4439-4845-B689-BF9DE21724C8Q34171997-6AE8992E-0710-4289-899B-760708CD1BA0Q34289358-3B9DCC86-C80B-4344-B84F-4F74E3367409Q34339759-B083F19C-C3FE-4232-958C-649EAF305C6DQ34542721-54DAC81F-D90C-448F-804E-EB7AA0F7A88FQ34660049-7708C9DE-4698-43A3-9AE7-2CC8AFF285A2Q35642250-16E77868-C45E-4310-8F67-0FCC1CD65DF3Q35780939-E0AABAFF-FDAF-4D36-9E05-2DD4400A41D9Q36011319-D1A616E8-C5EC-41BC-8E60-1914074BF090Q36101228-DD4737AC-553D-4537-86F3-BFF47BE30EF1Q36399256-AD0699D8-9EED-4CEA-8D01-ACA2A7CE7F02Q36405959-C9E37D39-A969-4303-A674-B1F7F76AAF26Q36664243-63BCCEA7-654E-4D49-ABAD-8DC75900B10BQ36820509-BBB7B7BB-092C-47FE-9B03-C0DB697C1C78Q36824048-BAF01643-E5E6-4397-A04A-6842DFDF24A1Q37098594-A584AAF2-16E3-455C-BEDE-B81ACA0092E2Q37620329-43BC8205-628F-47E5-A039-55CD089F9086Q37650618-2AB0019D-2739-4EA4-AE30-AC83D1E286D8Q38742072-BE837EDA-38AC-4C66-9C6E-A2E1571D0706Q47710637-F2C8D1B3-F038-406C-B95D-B5BF7AB47FB0Q50068175-2E692A6E-D8AC-4BF5-9387-AB40371EE796Q51132892-31BFBEF8-2DB8-4008-83D2-5D19EEAB4072Q53453823-A6410C2E-86CB-4DD1-9D24-293C1B8D100B
P2860
Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Positive feedback between vasc ...... otaxin in ovarian cancer cells
@ast
Positive feedback between vasc ...... otaxin in ovarian cancer cells
@en
type
label
Positive feedback between vasc ...... otaxin in ovarian cancer cells
@ast
Positive feedback between vasc ...... otaxin in ovarian cancer cells
@en
prefLabel
Positive feedback between vasc ...... otaxin in ovarian cancer cells
@ast
Positive feedback between vasc ...... otaxin in ovarian cancer cells
@en
P2093
P2860
P1476
Positive feedback between vasc ...... otaxin in ovarian cancer cells
@en
P2093
Malgorzata M Ptaszynska
Mary L Stracke
Michael L Pendrak
Russell W Bandle
P2860
P304
P356
10.1158/1541-7786.MCR-07-0143
P577
2008-03-01T00:00:00Z